1. Rashid T, Darlington G, Kjeldsen-Kragh J, et al. Proteus IgG antibodies and C-reactive protein in English, Norwegian and Spanish patients with rheumatoid arthritis. Clin Rheumatol. 1999;18(3):190-195. doi:10. 1007/s100670050208
2. Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320(13):1360-1372. doi:10.1001/jama. 2018.13103
3. England BR, Tiong BK, Bergman MJ, et al. 2019 update of the American College of Rheumatology recommended rheumatoid arthritis disease activity measures. Arthritis Care Res (Hoboken). 2019;71(11):1540-1555. doi:10.1002/acr.23831
4. Colglazier CL, Sutej PG. Laboratory testing in the rheumatic diseases: a practical review. South Med J. 2005;98(2):185-189. doi: 10.1097/01.smj. 0000153103.06303
5. Erre GL, Paliogiannis P, Castagna F, et al. Meta-analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in rheumatoid arthritis. Eur J Clin Invest. 2019;49(10):e13037. doi:10.1111/eci.13037
6. Ulutaş F, Çobankara V. Pan-immune-inflammation value (PIIV) in lupus nephritis. Med Sci Discov. 2023;10(3):234-238. doi:10.17546/msd. 1200
7. Baba Y, Nakagawa S, Toihata T, et al. Pan-immune-inflammation value and prognosis in patients with esophageal cancer. Ann Surg Open. 2021; 3(1):e113. doi:10.1097/AS9.0000000000000113
8. Dincer ABK, Sezer S. Systemic immune inflammation index as a reliable disease activity marker in psoriatic arthritis. J Coll Physicians Surg Pak. 2022;32(6):773-778. doi:10.29271/jcpsp.2022.06.773
9. Ozdemir A, Baran E, Kutu M, et al. Could systemic immune inflammation index be a new parameter for diagnosis and disease activity assessment in systemic lupus erythematosus? Int Urol Nephrol. 2023;55(1):211-216. doi:10.1007/s11255-022-03355-4
10. Zhang P, Li Y, Zhang H, et al. Prognostic value of the systemic inflammation response index in patients with aneurysmal subarachnoid hemorrhage. Br J Neurosurg. 2020;34(1):1-7. doi:10.1080/02688697.2019. 1632117
11. Chao B, Ju X, Zhang L, et al. A novel prognostic marker, systemic inflammation response index (SIRI) for operable cervical cancer patients. Front Oncol. 2020;10:766. doi:10.3389/fonc.2020.00766
12. Pacheco-Barcia V, Solís RM, France T, et al. A systemic inflammation response index (SIRI) correlates with survival in metastatic pancreatic cancer. Pancreatology. 2020;20(2):254-264. doi:10.1016/j.pan.2019.11.013
13. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria. Arthritis Rheum. 2010;62(9):2569-2581. doi:10. 1002/art.27584
14. Tutan D, Doğan AG. Pan-immune-inflammation index as a biomarker for RA progression. Cureus. 2023;15(4):e46609. doi:10.7759/cureus.46609
15. Delgado DA, Lambert BS, Boutris N, et al. Validation of digital visual analog scale pain scoring with a traditional paper-based visual analog scale in adults. J Am Acad Orthop Surg Glob Res Rev. 2018;2(3):e088. doi:10.5435/JAAOSGlobal-D-18-00088
16. de Bandt M, Fautrel B, Maillefert JF, et al. Determining a low disease activity threshold for DMARD continuation in RA. Arthritis Res Ther. 2009;11(4):R157. doi:10.1186/ar2796
17. Ulutaş F, Aydın M. Pan-immune-inflammation value in FMF patients. Med Sci Discov. 2023;10(4):364-367. doi:10.17546/msd.1212
18. Yoshikawa T, Furukawa T, Tamura M, et al. Systemic immune-inflammation index in RA patients: relation to disease activity. Ann Rheum Dis. 2019;78(3):325. doi:10.1136/annrheumdis-2018-eular.3741
19. Okutan İ, Aci R, Keskin Â, et al. New inflammatory markers in RA: PIV, SII, and SIRI. Reumatologia. 2024;62(6):439-446. doi:10.5114/reum.2024.124231
20. Dervisevic A, Fajkic A, Jahic E, et al. Systemic immune-inflammation index in RA patients. Medeni Med J. 2024;39(3):183-191. doi:10.5222/MMJ.2024.183
21. Bai J, Tian Y, Wang F, et al. Role of systemic immune-inflammation index in assessing tumor necrosis factor-α inhibitor efficacy in rheumatoid arthritis. Am J Transl Res. 2023;15:6524-6533. doi:10.7150/ajtr.86597
22. Jang DI, Lee AH, Shin HY, et al. The role of TNF-alpha in autoimmune disease and therapeutics. Int J Mol Sci. 2021;22(5):2719. doi:10.3390/ijms2205271
23. Liu B, Wang J, Li YY, Li KP, Zhang Q. The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999-2018. Arthritis Res Ther. 2023; 25(1): 34. doi:10.1186/s13075-023-03018-6
24. Başaran PÖ, Doğan M. Relationship between disease activity and PIV/SII in RA. Medicine (Baltimore). 2024;103(9):e37230. doi:10.1097/MD. 0000000000037230
25. Peng XC, Yin R, Luo LP, Xu S, Shuai Z. Rheumatoid factor titer as an indicator of the risk of rheumatoid arthritis activity: dose-effect analysis with the restricted cubic spline model. J Inflamm Res. 2024;17:10699-10709. doi:10.2147/JIR.S488605
26. Mikuls TR, O’Dell JR, Stoner JA, et al. Association of rheumatoid arthritis treatment response and disease duration with declines in serum levels of IgM rheumatoid factor and anti-cyclic citrullinated peptide antibody. Arthritis Rheum. 2004;50(12):3776-3782. doi:10.1002/art.20659